Leonard S. Schleifer (born 1953) is the co-founder and chief ex...

Leonard S. Schleifer (born 1953) is the co-founder and chief ex...

wikipedia - 03 Oct 2020
Leonard S. Schleifer (born 1953) is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals.

Regeneron's CEO and CSO could nab a whopping $1.4B in bonuses—if the pipeline pumps up investors

FiercePharma - 06 Jan 2021
Regeneron's CEO and CSO could nab a whopping $1.4B in bonuses—if the pipeline pumps up investors ...

UPDATE 1-Regeneron says antibodies likely potent vs virus variants, Lilly concerned about S. Africa version

Reuters - 11 Jan 2021
UPDATE 1-Regeneron says antibodies likely potent vs virus variants, Lilly concerned about S. Africa version ...

Regeneron says COVID-19 antibody therapy will likely help against variants

Reuters - 11 Jan 2021
Regeneron says COVID-19 antibody therapy will likely help against variants ...

Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

Seeking Alpha - 11 Jan 2021
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) ...

JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business

BioPharma Dive - 12 Jan 2021
JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business ...

Regeneron CEO Leonard Schleifer '73 Involved in Trump Experimental COVID-19 Treatment

Cornell University The Cornell Daily Sun - 08 Oct 2020
Regeneron CEO Leonard Schleifer '73 Involved in Trump Experimental COVID-19 Treatment ...

Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021

PRNewswire - 21 Jan 2021
Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021 ...

Covid updates: Operation Warp Speed chief resigns; U.S. lowers age for vaccine eligibility

CNBC - 13 Jan 2021
Covid updates: Operation Warp Speed chief resigns; U.S. lowers age for vaccine eligibility ...

US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug

BioPharma Dive - 13 Jan 2021
US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug ...

Transcript: Regeneron CEO Leonard Schleifer on "Face the Nation," October 11, 2020

CBS News - 11 Oct 2020
Transcript: Regeneron CEO Leonard Schleifer on "Face the Nation," October 11, 2020 ...

CNBC Transcript: Regeneron Chairman and CEO Dr. Leonard Schleifer Speaks with CNBC's Meg Tirrell on "Squawk Box" Today

CNBC - 23 Nov 2020
CNBC Transcript: Regeneron Chairman and CEO Dr. Leonard Schleifer Speaks with CNBC's Meg Tirrell on "Squawk Box" Today ...

NY Candidate and Pharma Heir Faces Questions on Drug Pricing Independence

Sludge - 12 Jun 2020
NY Candidate and Pharma Heir Faces Questions on Drug Pricing Independence ...

Regeneron will provide 300,000 doses of Covid treatment for U.S. by early January, CEO Schleifer says

CNBC - 23 Nov 2020
Regeneron will provide 300,000 doses of Covid treatment for U.S. by early January, CEO Schleifer says ...

Coronavirus Variants Threaten Billion Dollar Stockpile Of Antibody Therapy

Gothamist - 17 Jan 2021
Coronavirus Variants Threaten Billion Dollar Stockpile Of Antibody Therapy ...

Regeneron Negotiates COVID-19 Supply To Beat Back Merck

Seeking Alpha - 22 Jan 2021
Regeneron Negotiates COVID-19 Supply To Beat Back Merck ...

JPM2021: BioNTech Aims for 2 Billion COVID-19 Vaccine Doses by End of 2021 and More

BioSpace - 12 Jan 2021
JPM2021: BioNTech Aims for 2 Billion COVID-19 Vaccine Doses by End of 2021 and More ...

Chinese food, Italian food and mice: The genius of Regeneron

Westfair Online - 25 Oct 2020
Chinese food, Italian food and mice: The genius of Regeneron ...

Trump's use of Regeneron's experimental coronavirus treatment creates 'very tough situation,' CEO says

CNBC - 05 Oct 2020
Trump's use of Regeneron's experimental coronavirus treatment creates 'very tough situation,' CEO says ...

BRIEF-Regeneron Pharma Says 2019 Compensation For CEO Leonard S. Schleifer $21.5 Mln Vs $26.5 Mln In 2018

Reuters - 24 Apr 2020
BRIEF-Regeneron Pharma Says 2019 Compensation For CEO Leonard S. Schleifer $21.5 Mln Vs $26.5 Mln In 2018 ...

Leonard Schleifer